Annual Total Liabilities
$81.86 M
+$73.25 M+850.73%
December 31, 2023
Summary
- As of February 7, 2025, ELDN annual total liabilities is $81.86 million, with the most recent change of +$73.25 million (+850.73%) on December 31, 2023.
- During the last 3 years, ELDN annual total liabilities has risen by +$75.27 million (+1142.34%).
- ELDN annual total liabilities is now -6.51% below its all-time high of $87.55 million, reached on December 31, 2013.
Performance
ELDN Total Liabilities Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
High & Low
Earnings dates
Quarterly Total Liabilities
$38.52 M
-$90.47 M-70.14%
September 30, 2024
Summary
- As of February 7, 2025, ELDN quarterly total liabilities is $38.52 million, with the most recent change of -$90.47 million (-70.14%) on September 30, 2024.
- Over the past year, ELDN quarterly total liabilities has increased by +$33.78 million (+713.65%).
- ELDN quarterly total liabilities is now -77.49% below its all-time high of $171.08 million, reached on September 30, 2020.
Performance
ELDN Quarterly Total Liabilities Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
High & Low
Earnings dates
Total Liabilities Formula
Total Liabilities = Current Liabilities + Long-Term Liabilities
ELDN Total Liabilities Trends
PeriodPeriod | AnnualAnnual | QuarterlyQuarterly |
---|---|---|
1 y1 year | +850.7% | +713.6% |
3 y3 years | +1142.3% | +713.6% |
5 y5 years | +3130.4% | +713.6% |
ELDN Total Liabilities Highs & Lows
PeriodPeriod | Annual vs highAnnual vs high | Annual vs lowAnnual vs low | Quarter. vs highQuarter. vs high | Quarter. vs lowQuarter. vs low | |
---|---|---|---|---|---|
3 y | 3-year | at high | +1149.2% | -70.1% | +713.6% |
5 y | 5-year | at high | +5483.8% | -77.5% | +3264.0% |
alltime | all time | -6.5% | +5584.6% | -77.5% | +3264.0% |
Eledon Pharmaceuticals Total Liabilities History
Date | Annual | Quarterly |
---|---|---|
Sep 2024 | - | $38.52 M(-70.1%) |
Jun 2024 | - | $128.98 M(+2050.1%) |
Mar 2024 | - | $6.00 M(-92.7%) |
Dec 2023 | $81.86 M(+850.7%) | $81.86 M(+1629.2%) |
Sep 2023 | - | $4.73 M(-30.7%) |
Jun 2023 | - | $6.84 M(-9.0%) |
Mar 2023 | - | $7.51 M(-12.7%) |
Dec 2022 | $8.61 M(+31.4%) | $8.61 M(+1.4%) |
Sep 2022 | - | $8.49 M(+59.4%) |
Jun 2022 | - | $5.33 M(+5.3%) |
Mar 2022 | - | $5.06 M(-22.8%) |
Dec 2021 | $6.55 M(-0.5%) | $6.55 M(+2.0%) |
Sep 2021 | - | $6.42 M(+11.0%) |
Jun 2021 | - | $5.78 M(-26.0%) |
Mar 2021 | - | $7.81 M(+18.5%) |
Dec 2020 | $6.59 M(+349.5%) | $6.59 M(-96.1%) |
Sep 2020 | - | $171.08 M(>+9900.0%) |
Jun 2020 | - | $1.15 M(-42.0%) |
Mar 2020 | - | $1.98 M(+34.7%) |
Dec 2019 | $1.47 M | $1.47 M(-20.8%) |
Sep 2019 | - | $1.85 M(-15.2%) |
Jun 2019 | - | $2.18 M(-38.0%) |
Date | Annual | Quarterly |
---|---|---|
Mar 2019 | - | $3.52 M(+39.0%) |
Dec 2018 | $2.53 M(+76.0%) | $2.53 M(+58.1%) |
Sep 2018 | - | $1.60 M(+10.4%) |
Jun 2018 | - | $1.45 M(-10.3%) |
Mar 2018 | - | $1.62 M(+12.4%) |
Dec 2017 | $1.44 M(-63.1%) | $1.44 M(-40.0%) |
Sep 2017 | - | $2.40 M(-29.5%) |
Jun 2017 | - | $3.40 M(+38.0%) |
Mar 2017 | - | $2.47 M(-36.7%) |
Dec 2016 | $3.90 M(-37.6%) | $3.90 M(-39.7%) |
Sep 2016 | - | $6.46 M(-18.9%) |
Jun 2016 | - | $7.97 M(+26.5%) |
Mar 2016 | - | $6.30 M(+0.8%) |
Dec 2015 | $6.25 M(+47.3%) | $6.25 M(+9.5%) |
Sep 2015 | - | $5.71 M(+22.5%) |
Jun 2015 | - | $4.66 M(-19.0%) |
Mar 2015 | - | $5.75 M(+35.6%) |
Dec 2014 | $4.24 M(-95.2%) | $4.24 M(-21.0%) |
Sep 2014 | - | $5.37 M(+45.7%) |
Jun 2014 | - | $3.69 M(-95.8%) |
Dec 2013 | $87.55 M(+68.8%) | $87.55 M |
Dec 2012 | $51.86 M | - |
FAQ
- What is Eledon Pharmaceuticals annual total liabilities?
- What is the all time high annual total liabilities for Eledon Pharmaceuticals?
- What is Eledon Pharmaceuticals annual total liabilities year-on-year change?
- What is Eledon Pharmaceuticals quarterly total liabilities?
- What is the all time high quarterly total liabilities for Eledon Pharmaceuticals?
- What is Eledon Pharmaceuticals quarterly total liabilities year-on-year change?
What is Eledon Pharmaceuticals annual total liabilities?
The current annual total liabilities of ELDN is $81.86 M
What is the all time high annual total liabilities for Eledon Pharmaceuticals?
Eledon Pharmaceuticals all-time high annual total liabilities is $87.55 M
What is Eledon Pharmaceuticals annual total liabilities year-on-year change?
Over the past year, ELDN annual total liabilities has changed by +$73.25 M (+850.73%)
What is Eledon Pharmaceuticals quarterly total liabilities?
The current quarterly total liabilities of ELDN is $38.52 M
What is the all time high quarterly total liabilities for Eledon Pharmaceuticals?
Eledon Pharmaceuticals all-time high quarterly total liabilities is $171.08 M
What is Eledon Pharmaceuticals quarterly total liabilities year-on-year change?
Over the past year, ELDN quarterly total liabilities has changed by +$33.78 M (+713.65%)